Douche complaints, demographics requested from industry in FDA letter.
This article was originally published in The Rose Sheet
Executive Summary
VAGINAL DOUCHE USE PATTERNS, COMPLAINT INFO REQUESTED BY FDA in a Feb. 19 letter to douche manufacturers and associated trade groups from the agency's Division of OTC Drug Products Director Debra Bowen, MD. The letter was issued to solicit information in preparation for the April 15 joint meeting of FDA's Nonprescription Drugs, Anti-infective Drugs and Reproductive Drugs Advisory Committees and members from the Center for Devices & Radiological Health, to review vaginal douche safety ("The Rose Sheet" Feb. 24, p. 6).